Edition:
United Kingdom

Insider Trading: Biogen Inc (BIIB.OQ)

BIIB.OQ on NASDAQ Stock Exchange Global Select Market

228.81USD
22 Apr 2019
Change (% chg)

$2.42 (+1.07%)
Prev Close
$226.39
Open
$226.99
Day's High
$232.18
Day's Low
$226.99
Volume
550,790
Avg. Vol
707,692
52-wk High
$388.67
52-wk Low
$216.13

All Insider Trades
Trading Date Name Title Type Shares Traded Price
18 Mar 2019

Pangia (Robert W)

Director Buy 6,114 $52.22
18 Mar 2019

Pangia (Robert W)

Director Sell 6,114 $328.55
1 Mar 2019

McKenzie (Paul F Ph.D.)

Officer Sell 405 $334.10
1 Mar 2019

McKenzie (Paul F Ph.D.)

Officer Buy 568 $0.00
1 Mar 2019

McKenzie (Paul F Ph.D.)

Officer Sell 253 $334.10
22 Feb 2019

Alexander (Susan H)

Officer Buy 1,663 $0.00
22 Feb 2019

Alexander (Susan H)

Officer Sell 3,370 $325.33
22 Feb 2019

Alexander (Susan H)

Officer Buy 6,395 $49.65
22 Feb 2019

Sandrock Alfred W Jr

Officer Sell 739 $325.33
22 Feb 2019

Sandrock Alfred W Jr

Officer Buy 1,663 $0.00
22 Feb 2019

Alexander (Susan H)

Officer Sell 739 $325.33
15 Feb 2019

Sandrock Alfred W Jr

Officer Buy 1,318 $0.00
15 Feb 2019

McKenzie (Paul F Ph.D.)

Officer Sell 643 $332.87
15 Feb 2019

McKenzie (Paul F Ph.D.)

Officer Buy 1,448 $0.00
15 Feb 2019

Sandrock Alfred W Jr

Officer Sell 586 $332.87
15 Feb 2019

Alexander (Susan H)

Officer Buy 1,685 $0.00
15 Feb 2019

Vounatsos (Michel)

Chief Executive Officer Sell 2,340 $332.87
15 Feb 2019

Vounatsos (Michel)

Chief Executive Officer Buy 5,269 $0.00
15 Feb 2019

Ehlers (Michael D M.D., Ph.D.)

Officer Sell 749 $332.87
15 Feb 2019

Ehlers (Michael D M.D., Ph.D.)

Officer Buy 1,685 $0.00
15 Feb 2019

Alexander (Susan H)

Officer Sell 749 $332.87
14 Feb 2019

Posner (Brian S)

Director Gift 315 $0.00
12 Feb 2019

McKenzie (Paul F Ph.D.)

Officer Sell 539 $319.43
12 Feb 2019

McKenzie (Paul F Ph.D.)

Officer Buy 1,263 $0.00
12 Feb 2019

McKenzie (Paul F Ph.D.)

Officer Sell 380 $319.43

Institutional Holders

% Shares Owned: 93.50%
# of Holders: 1,586
Total Shares Held: 183,915,914
3 Mo. Net Change: 74,391
# New Positions: 25
# Closed Positions: 30
# Increased Positions: 115
# Reduced Positions: 135
# Net Buyers: -20

Officers & Directors

Name Age Since Current Position

Stelios Papadopoulos

69 2014 Independent Chairman of the Board

Michel Vounatsos

57 2017 Chief Executive Officer, Director

Jeffrey Capello

54 2018 Chief Financial Officer, Executive Vice President

Ginger Gregory

51 2017 Chief Human Resource Officer, Executive Vice President

Susan Alexander

62 2018 Executive Vice President, Chief Legal Officer and Secretary

Michael Ehlers

50 2016 Executive Vice President, Research and Development

Chirfi Guindo

53 2017 Executive Vice President, Head of Global Marketing, Market Access and Customer Innovation

Daniel Karp

41 2018 Executive Vice President, Corporate Development

Paul McKenzie

53 2016 Executive Vice President, Pharmaceutical Operations & Technology

Alfred Sandrock

61 2017 Executive Vice President, Chief Medical Officer

Robin Kramer

53 2018 Chief Accounting Officer, Vice President

Alexander Denner

48 2009 Independent Director

Caroline Dorsa

58 2010 Independent Director

Nancy Leaming

70 2008 Independent Director

Richard Mulligan

63 2009 Independent Director

Robert Pangia

66 1997 Independent Director

Brian Posner

56 2008 Independent Director

Eric Rowinsky

61 2010 Independent Director

Lynn Schenk

73 1995 Independent Director

Stephen Sherwin

69 2010 Independent Director